Institutional investors purchased a net $13.4 million shares of KERX during the quarter ended March 2014 and now own 81.36% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEERFIELD MANAGEMENT CO. LP Bought 3.1 Million shares of Keryx Biopharmaceuticals ...
THE BAUPOST GROUP LLC Bought 2.8 Million shares of Keryx Biopharmaceuticals ...